DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,244 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $3,945,576 | -19.8% | 15,800 | -25.7% | 0.04% | -13.0% |
Q4 2023 | $4,921,759 | -71.6% | 21,275 | -69.6% | 0.05% | -75.3% |
Q3 2023 | $17,341,446 | +275.8% | 69,897 | +263.6% | 0.19% | +313.3% |
Q2 2023 | $4,614,000 | -56.2% | 19,225 | -54.0% | 0.04% | -56.3% |
Q1 2023 | $10,544,093 | -50.1% | 41,835 | -47.5% | 0.10% | -44.9% |
Q4 2022 | $21,134,598 | -45.7% | 79,627 | -47.2% | 0.19% | -37.5% |
Q3 2022 | $38,938,000 | +5.5% | 150,752 | +3.5% | 0.30% | +13.3% |
Q2 2022 | $36,909,000 | -29.8% | 145,587 | -18.8% | 0.26% | -12.3% |
Q1 2022 | $52,568,000 | -24.7% | 179,210 | -15.6% | 0.30% | -29.8% |
Q4 2021 | $69,829,000 | +40.3% | 212,241 | +29.8% | 0.43% | -0.2% |
Q3 2021 | $49,784,000 | -10.9% | 163,527 | -21.4% | 0.43% | -7.3% |
Q2 2021 | $55,846,000 | +19.2% | 208,100 | -0.0% | 0.46% | +11.0% |
Q1 2021 | $46,862,000 | +12.3% | 208,200 | +10.8% | 0.42% | +13.9% |
Q4 2020 | $41,740,000 | +32.1% | 187,900 | +28.1% | 0.37% | +7.3% |
Q3 2020 | $31,589,000 | -15.1% | 146,700 | -30.3% | 0.34% | -23.0% |
Q2 2020 | $37,223,000 | +235.3% | 210,500 | +162.5% | 0.44% | +125.4% |
Q1 2020 | $11,100,000 | +72.2% | 80,200 | +91.0% | 0.20% | +264.8% |
Q4 2019 | $6,446,000 | +41.2% | 42,000 | +32.9% | 0.05% | +25.6% |
Q3 2019 | $4,564,000 | -71.1% | 31,600 | -71.4% | 0.04% | -69.9% |
Q2 2019 | $15,793,000 | +5.7% | 110,500 | -2.4% | 0.14% | +2.1% |
Q1 2019 | $14,945,000 | +192.2% | 113,200 | +128.2% | 0.14% | +154.5% |
Q4 2018 | $5,115,000 | -34.9% | 49,600 | -38.2% | 0.06% | -24.7% |
Q1 2018 | $7,852,000 | +125.6% | 80,200 | +113.9% | 0.07% | +143.3% |
Q4 2017 | $3,481,000 | -68.4% | 37,500 | -70.8% | 0.03% | -70.9% |
Q3 2017 | $11,031,000 | -0.6% | 128,600 | -2.2% | 0.10% | -1.0% |
Q2 2017 | $11,097,000 | +17.7% | 131,500 | +19.3% | 0.10% | +28.4% |
Q1 2017 | $9,425,000 | -23.6% | 110,200 | -30.5% | 0.08% | -27.7% |
Q4 2016 | $12,338,000 | +10.1% | 158,500 | +10.8% | 0.11% | +1.8% |
Q3 2016 | $11,210,000 | +17.2% | 143,000 | +51.0% | 0.11% | +0.9% |
Q2 2016 | $9,565,000 | +20.5% | 94,700 | +13.1% | 0.11% | +4.8% |
Q1 2016 | $7,940,000 | +25.0% | 83,700 | +22.4% | 0.10% | +40.5% |
Q4 2015 | $6,353,000 | +95.7% | 68,400 | +79.5% | 0.07% | +94.7% |
Q3 2015 | $3,247,000 | -43.4% | 38,100 | -43.6% | 0.04% | -36.7% |
Q1 2015 | $5,739,000 | -36.4% | 67,600 | -35.7% | 0.06% | -37.5% |
Q4 2014 | $9,017,000 | +949.7% | 105,200 | +715.5% | 0.10% | +357.1% |
Q2 2013 | $859,000 | – | 12,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |